Ropes & Gray advised Adaptimmune Therapeutics on the transaction.Adaptimmune Therapeutics (NASDAQ: ADAP) announced it has entered into a clinical collaboration agreement with Galapagos NV (Euronext &…
Adaptimmune’s Clinical Collaboration Agreement with Galapagos
![](https://globallegalchronicle.com/wp-content/uploads/2024/06/adaptimmunes-clinical-collaboration-agreement-with-galapagos_666011444a3f0.jpeg)